.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
QuintilesIMS
Fish and Richardson
Johnson and Johnson
Deloitte
Colorcon
UBS
Harvard Business School
Moodys

Generated: December 15, 2017

DrugPatentWatch Database Preview

REMERON Drug Profile

« Back to Dashboard

Which patents cover Remeron, and when can generic versions of Remeron launch?

Remeron is a drug marketed by Organon Usa Inc and is included in two NDAs.

The generic ingredient in REMERON is mirtazapine. There are eighteen drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the mirtazapine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-001Jun 14, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERON SOLTABmirtazapineTABLET, ORALLY DISINTEGRATING;ORAL021208-001Jan 12, 2001ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-002Jun 14, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-003Mar 17, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERON SOLTABmirtazapineTABLET, ORALLY DISINTEGRATING;ORAL021208-003Jan 12, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Organon Usa IncREMERON SOLTABmirtazapineTABLET, ORALLY DISINTEGRATING;ORAL021208-002Jan 12, 2001ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REMERON

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-001Jun 14, 1996► Subscribe► Subscribe
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-003Mar 17, 1997► Subscribe► Subscribe
Organon Usa IncREMERONmirtazapineTABLET;ORAL020415-002Jun 14, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Chinese Patent Office
Dow
Deloitte
US Department of Justice
McKinsey
Covington
Cerilliant
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot